These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8500606)
1. Phospholipid determination in platelets, plasma and red cells of patients with chronic myeloproliferative disorders. Cesar JM; Vecino A; Perez-Vaquero M; Navarro JL Eur J Haematol; 1993 Apr; 50(4):234-6. PubMed ID: 8500606 [TBL] [Abstract][Full Text] [Related]
2. Plasma and red blood cell phospholipids in chronic liver diseases. Cantoni L; Curri SB; Andreuzzi P; Rocchetti P Clin Chim Acta; 1975 May; 60(3):405-8. PubMed ID: 1139785 [TBL] [Abstract][Full Text] [Related]
3. Platelet phospholipids in thrombocytosis due to myeloproliferative disorders. Breuer JH; Harsányi V; Solti V; Hollán SR Haemostasis; 1981; 10(3):134-40. PubMed ID: 7262643 [TBL] [Abstract][Full Text] [Related]
4. Decreased erythrocyte and platelet phospholipids and fatty acids in juvenile neuronal ceroid-lipofuscinosis (Batten disease). Bennett MJ; Galloway JH; Cartwright IJ; Gillis WS; Hosking GP Neuropediatrics; 1990 Nov; 21(4):202-5. PubMed ID: 2290481 [TBL] [Abstract][Full Text] [Related]
5. [Phospholipids and platelet procoagulant activity in myeloproliferative syndromes]. Martínez E; César J; Navarro JL; Mercado A; Pardo A; García Avello A; García Frade J Sangre (Barc); 1985; 30(1):22-7. PubMed ID: 4039850 [No Abstract] [Full Text] [Related]
6. Externalization of aminophospholipids in platelet liposome bilayers by supplementation with sphingomyelin. Sánchez-Yagüe J; Cabezas JA; Llanillo M Biochem Int; 1988 May; 16(5):809-14. PubMed ID: 3421982 [TBL] [Abstract][Full Text] [Related]
7. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy. Ryningen A; Apelseth T; Hausken T; Bruserud Ø Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601 [TBL] [Abstract][Full Text] [Related]
8. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders. Yamamoto K; Sekiguchi E; Takatani O Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753 [TBL] [Abstract][Full Text] [Related]
9. A comparison of platelet monoamine oxidase activity and phosphatidylserine content between chronic paranoid schizophrenics and normal controls. Orologas AG; Buckman TD; Eiduson S Neurosci Lett; 1986 Aug; 68(3):293-8. PubMed ID: 3748456 [TBL] [Abstract][Full Text] [Related]
10. Phospholipid composition of Down's syndrome and normal platelets. Strynadka K; McCoy EE Clin Biochem; 1978 Apr; 11(2):35-7. PubMed ID: 148336 [TBL] [Abstract][Full Text] [Related]
11. Lipid composition of platelets in patients with uremia. Vecino A; Navarro-Antolín J; Teruel J; Navarro J; Cesar J Nephron; 1998; 78(3):271-3. PubMed ID: 9546685 [TBL] [Abstract][Full Text] [Related]
12. Composition of platelet phospholipids after moderate consumption of red wine in healthy volunteers. Pellegrini N; Simonetti P; Brusamolino A; Bottasso B; Pareti FI Eur J Clin Nutr; 1996 Aug; 50(8):535-44. PubMed ID: 8863014 [TBL] [Abstract][Full Text] [Related]
13. Transverse redistribution of phospholipids during human platelet activation: evidence for a vectorial outflux specific to aminophospholipids. Gaffet P; Bettache N; Bienvenüe A Biochemistry; 1995 May; 34(20):6762-9. PubMed ID: 7756307 [TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia. Bräutigam R; Bräutigam C; Lorenz R; Richter WO; Engelmann B Atherosclerosis; 1997 May; 131(1):97-106. PubMed ID: 9180250 [TBL] [Abstract][Full Text] [Related]
15. Alterations in individual molecular species of human platelet phospholipids during thrombin stimulation: electrospray ionization mass spectrometry-facilitated identification of the boundary conditions for the magnitude and selectivity of thrombin-induced platelet phospholipid hydrolysis. Han X; Gubitosi-Klug RA; Collins BJ; Gross RW Biochemistry; 1996 May; 35(18):5822-32. PubMed ID: 8639543 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disorders. Cooper B; Ahern D J Clin Invest; 1979 Aug; 64(2):586-90. PubMed ID: 222813 [TBL] [Abstract][Full Text] [Related]